From a therapeutic perspective, targeting YTHDF1 and TFRC-mediated iron metabolism to promote iron homeostasis imbalance may be a promising strategy for treating HNSCC. This evidence concerns the gene YTHDF1 and head and neck squamous cell carcinoma.